About
Anuj Gaggar, MD, PhD, is a biotech physician-executive focused on antiviral drug development. He has served as Chief Medical Officer of Assembly Biosciences since November 2023 after co-founding and leading Arrive Bio and spending nearly a decade in clinical research leadership at Gilead Sciences. His work has centered on hepatitis B, hepatitis C, hepatitis D, and other antiviral programs, and he has been credited with more than 95 publications.
Areas of interest
biotechantiviral therapeuticsinfectious diseaseclinical developmentvirologyhepatitis Bhepatitis Chepatitis D